These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8920906)

  • 41. Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.
    Date I; Shingo T; Ohmoto T; Emerich DF
    Exp Neurol; 1997 Sep; 147(1):10-7. PubMed ID: 9294398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell therapy of pain: Characterization of human fetal chromaffin cells at early adrenal medulla development.
    Zhou H; Aziza J; Sol JC; Courtade-Saïdi M; Chatelin S; Evra C; Parant O; Lazorthes Y; Jozan S
    Exp Neurol; 2006 Apr; 198(2):370-81. PubMed ID: 16443224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats.
    Borlongan CV; Saporta S; Sanberg PR
    Exp Neurol; 1998 Jun; 151(2):203-14. PubMed ID: 9628755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential regulation of multiple populations of granules in rat adrenal chromaffin cells by culture duration and cyclic AMP.
    Tang KS; Tse A; Tse FW
    J Neurochem; 2005 Mar; 92(5):1126-39. PubMed ID: 15715663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chromaffin cells in the adrenal homolog of Aphanius fasciatus (teleost fish) express piecemeal degranulation in response to osmotic stress: a hint for a conservative evolutionary process.
    Crivellato E; Civinini A; Gallo VP
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Oct; 288(10):1077-86. PubMed ID: 16964607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Automated method for isolation of adrenal medullary chromaffin cells from neonatal porcine glands.
    Vizzardelli C; Potter ED; Berney T; Pileggi A; Inverardi L; Ricordi C; Sagen J
    Cell Transplant; 2001; 10(8):689-96. PubMed ID: 11814111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.
    May SW; Herman HH; Roberts SF; Ciccarello MC
    Biochemistry; 1987 Mar; 26(6):1626-33. PubMed ID: 3036204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of chromaffin cells from several animal sources for their use as an in vitro model to study the mechanism of organophosphorous toxicity.
    Romero D; Quesada E; Sogorb MA; García-Fernández AJ; Vilanova E; Carrera V
    Toxicol Lett; 2006 Sep; 165(3):221-9. PubMed ID: 16797889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine-beta-hydroxylase.
    Rosenberg RC; Lovenberg W
    Essays Neurochem Neuropharmacol; 1980; 4():163-209. PubMed ID: 6248338
    [No Abstract]   [Full Text] [Related]  

  • 50. Multiple pathways in regulation of dopamine beta-hydroxylase.
    Sabban EL; Nankova BB
    Adv Pharmacol; 1998; 42():53-6. PubMed ID: 9327845
    [No Abstract]   [Full Text] [Related]  

  • 51. Chromaffin granules: a new look at an old discovery.
    Blaschko H
    Adv Biochem Psychopharmacol; 1980; 25():251-3. PubMed ID: 7446258
    [No Abstract]   [Full Text] [Related]  

  • 52. [Studies on catecholamine biosynthesis. IV. Inhibition of dopamine beta-hydroxylase by thiourea derivatives (author's transl)].
    Ozawa H; Oyama H
    Yakugaku Zasshi; 1975 Apr; 95(4):373-7. PubMed ID: 1099190
    [No Abstract]   [Full Text] [Related]  

  • 53. A simplified method for raising antibodies to rat dopamine-beta-hydroxylase.
    Helle KB; Fillenz M; Stanford C; Pihl KE; Srebro B
    J Neurochem; 1979 Apr; 32(4):1351-5. PubMed ID: 372498
    [No Abstract]   [Full Text] [Related]  

  • 54. Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.
    Colombo G; Rajashekhar B; Giedroc DP; Villafranca JJ
    J Biol Chem; 1984 Feb; 259(3):1593-600. PubMed ID: 6693426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.
    May SW; Mueller PW; Padgette SR; Herman HH; Phillips RS
    Biochem Biophys Res Commun; 1983 Jan; 110(1):161-8. PubMed ID: 6860408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversible penetration of alpha-glutathione S-transferase into biological membranes revealed by photosensitized labelling in situ.
    Merezhinskaya N; Kuijpers GA; Raviv Y
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):597-604. PubMed ID: 9794800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel antihypertensives targeted at dopamine beta-monooxygenase: turnover-dependent cofactor depletion by phenyl aminoethyl selenide.
    May SW; Wimalasena K; Herman HH; Fowler LC; Ciccarello MC; Pollock SH
    J Med Chem; 1988 Jun; 31(6):1066-8. PubMed ID: 3373481
    [No Abstract]   [Full Text] [Related]  

  • 58. Activation of bovine adrenal dopamine beta-hydroxylase by ADP and other nucleotides.
    Tachikawa E; Ohuchi T; Morita K; Ishimura Y; Oka M; Izumi F
    FEBS Lett; 1979 Apr; 100(2):331-3. PubMed ID: 456570
    [No Abstract]   [Full Text] [Related]  

  • 59. Structural requirements for cocaine-sensitive and -insensitive uptake of phenethylamines into the adrenal chromaffin cell.
    Powers JL; Plaskon RR; Olsen GA; May SW
    J Neurochem; 1995 Nov; 65(5):2031-42. PubMed ID: 7595487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of inhibition of dopamine beta-monooxygenase by quinol and phenol derivatives, as determined by solvent and substrate deuterium isotope effects.
    Kim SC; Klinman JP
    Biochemistry; 1991 Aug; 30(33):8138-44. PubMed ID: 1868089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.